Anticancer, Inc.
United StatesFDA applicant, unverified
- Devices
- 3
What Anticancer, Inc. makes
Anticancer, Inc. manufactures enzymatic assay devices for measuring vitamin B6 and homocysteine levels, including portable and laboratory versions. These products are designed for clinical and research settings to quantify biochemical markers in blood or serum samples.
The company’s enzymatic assay devices are classified as Class II under FDA regulations and are authorised through the 510(k) clearance process. These products are listed in the FDA’s 510(k) registry, reflecting their compliance with US medical device standards.
Catalogue
A/C Enzymatic Vitamin B6 Assay Ref K111260
Regimes: 510(k) Registry: 510(k)A/C Portable Enzymatic Homocysteine Assay Ref K080851
Regimes: 510(k) Registry: 510(k)A/C Enzymatic Homocysteine Assay Ref K030754
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Anticancer, Inc. have in the registry?
The registry currently lists 3 devices for Anticancer, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Anticancer, Inc.'s devices?
Among its 3 most recently registered devices, Anticancer, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Anticancer, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Anticancer, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Anticancer, Inc. in the registry?
The most recently registered devices listed for Anticancer, Inc. include A/C ENZYMATIC VITAMIN B6 ASSAY, A/C PORTABLE ENZYMATIC HOMOCYSTEINE ASSAY and A/C ENZYMATIC HOMOCYSTEINE ASSAY.